Cardiology

Your Article Summary

See Latest Articles

Use of inotropic and vasopressor substances in acute decompensated heart failure
Intensivmedizin und Notfallmedizin, 09/08/09

Geppert A – From a therapeutic viewpoint, revascularization/reperfusion in ischemia–triggered heart failure and antiarrhythmic agents in arrhythmia–triggered heart failure are essential pillars in the therapy of acute decompensated heart failure. Pharmaceutical treatment with inotropic agents and vasopressors can also be viewed as basic in the treatment of severe refractory acute decompensated heart failure.

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09

Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
The American Journal of Cardiology, 11/05/09

Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09

See All of Clinical Pharmacology

Today in Heart Failure...keeping you current

Receive free subspecialty "5-minute updates" via email

Omega-3 fatty acids and heart failure
Current Atherosclerosis Reports, 11/12/09

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
The Lancet - Early Online Publication, 11/18/09

Coenzyme Q10; an adjunctive therapy for congestive heart failure?
New Zealand Medical Journal, 11/04/09

See All of Heart Failure